Myocardial infarction after electroconvulsive therapy;Infarto agudo de miocardio tras terapia electroconvulsiva

Revista Espanola de Cardiologia

Volumn 52, Issue 7, 1999, Pages 536-538

  López Gómez, David ^a   Sánchez Corral, Miguel A ^a   Cobo, Jesús V ^a   Jara, Francisco ^a   Esplugas, Enric ^a  

^a NONE

Author keywords

Beta blockers; Electroconvulsive therapy; Myocardial infarction

Indexed keywords

AGED; ARTICLE; CASE REPORT; ELECTROCONVULSIVE THERAPY; FEMALE; HEART INFARCTION; HUMAN;

AGED; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MYOCARDIAL INFARCTION;

EID: 0039030361     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(99)74966-3     Document Type: Article

References (7)

1. Electroconvulsive Therapy. NIH Consens Statement 1985; 5: 1-23.
2. Hussar AE, Pachter M. Myocardial infarction and fatal coronary insufficiency during electroconvulsive therapy. JAMA 1968; 204: 146-148.
3. Kovac AL, Goto H, Arakawa K, Pardo MP. Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy. Can J Anesthesiol 1990, 37: 58-62.
4. Howie MB, Hiestand DC, Zvara DA, Kim PY, McSweeney TD, Coffman JA. Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation. Anesth Analg 1992; 75: 805-810.
5. Castelli I, Steiner LA, Kaufmann MA, Alfillé PH, Schouten R, Welch CA et al. Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy. Anesth Analg 1995; 80: 557-561.
6. Mander AJ, Whitfield A, Kean DM, Smith MA, Douglas RHB, Kendell RE. Cerebral and brain stem changes after electroconvulsive therapy revealed by nuclear magnetic resonance imaging. Br J Psychiatry 1987; 151: 69-71.
7. Petrides G, Fink M. Atrial fibrillation, anticoagulation, and electroconvulsive therapy. Convuls Ther 1996; 12: 91-98.